Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial

Introduction Long COVID-19, where symptoms persist 12 weeks after the initial SARS-CoV-2-infection, is a substantial problem for individuals and society in the surge of the pandemic. Common symptoms are fatigue, postexertional malaise and cognitive dysfunction. There is currently no effective treatm...

Full description

Bibliographic Details
Main Authors: Carl Johan Sundberg, Kenny A Rodriguez-Wallberg, John Pernow, Judith Bruchfeld, Xiaowei Zheng, Michael Runold, Peter Lindholm, Anders Kjellberg, Jan H Kowalski, Sergiu Catrina, Lina Abdel-Halim, Adrian Hassler, Sara El Gharbi, Sarah Al-Ezerjawi, Emil Boström, Koshiar Medson, Marcus Ståhlberg, Malin Nygren-Bonnier
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/11/e061870.full

Internet

https://bmjopen.bmj.com/content/12/11/e061870.full

Similar Items